The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.
about
Accelerated atherosclerosis in patients with SLE--mechanisms and managementCardiovascular disease in lupus: insights and updatesA meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those withoutThe inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupusIntegrative biology identifies shared transcriptional networks in CKD.The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.Atherosclerosis in systemic lupus erythematosus.Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.Adjuvant therapy: melanomaInterleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitorsRoles of pro- and anti-inflammatory cytokines in the pathogenesis of SLEEndothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.Plasmacytoid dendritic cells in atherosclerosis.Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritisType I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisRelation of peritubular capillary features to class of lupus nephritisIncreased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.Modulation of Endothelial Injury Biomarkers by Traditional Chinese Medicine LC in Systemic Lupus Erythematosus Patients Receiving Standard Treatments.Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophagesTaming lupus-a new understanding of pathogenesis is leading to clinical advances.What is damaging the kidney in lupus nephritis?Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compoundCardiovascular risk in pediatric-onset rheumatological diseases.From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patientsTofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.The role IL-1 in tumor-mediated angiogenesis.Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.Developing Treatments for Chronic Kidney Disease in the 21st Century.The next generation of therapeutics for chronic kidney diseaseEndothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor.
P2860
Q26820245-94172AC5-88ED-4443-8916-0B868E8BEB38Q27016554-B3BF8B92-7BC3-4FB1-AE57-3E045F788ABDQ31142463-B29C2025-073B-40CE-8E3D-19640E50A0D4Q34127758-BC86C306-7A97-483C-9B60-D78EDAFAB9E8Q34240254-FB65600A-B770-4358-BF86-4536570C217EQ34273836-7C31EB93-51D1-426B-8C78-C362A44607EEQ34343906-8999A20C-3210-41E1-93FE-B6B0DD0B722DQ34427636-AB0669BF-5BE0-42F9-AB26-0B86288B9049Q35169351-ECA1410A-C92C-4616-A03F-0F15F5A8D767Q35236547-DAB5F0BF-2ADE-4A0A-A378-EE0DD25B7F02Q35525108-513D599D-FCD4-460D-8792-085E49B8445AQ35566819-973CF716-6093-42AA-9704-8122C7E485D2Q35634587-06FE68FE-7B27-4B18-A9A9-A5189B183152Q35636225-9B7E04CF-D6AE-44F2-97E6-984F64E2172BQ35661943-A3804731-047B-4823-BCC7-DA7E5CE1E921Q35829864-6786C1C1-F162-421F-8D40-7EF05B36490DQ35901110-EB3D67F9-1DAC-4762-9D53-6B26E53C24D3Q36064574-9AAC366A-4823-41F9-802E-18927DE33812Q36083938-50035D78-8729-49EE-8ED4-D25FFDAECA86Q36139902-0EB28F9B-7DA4-4B6E-A0AC-34F4BA040CB2Q36187823-ADF334D3-DF52-4F92-9443-4BF76ECB9EB8Q36312962-BB25AA5C-1CE0-40F8-93B4-C1EA5D7EB30AQ36421501-950CFF8A-FFB7-47CD-BD38-F46B5B4F78E1Q36548651-A66E30B1-4F95-4D9B-92CF-4968E35E0499Q36553792-C6E3D78A-01A0-4982-87D0-7145D6A615AAQ36712941-7D44AC71-4A9D-4F06-AC51-6AC4F4EDF4ACQ36765221-23CCDCB5-46AD-443E-80B9-CFC35B3BB6F1Q36839796-EC1943C2-6FBB-4B3E-832D-E73DF12744A0Q36903089-2BE90818-3290-48C8-A3BD-73B85B8B7ADCQ37014982-672CD4D3-FEC9-4D92-8C6B-84FD2D43385EQ37500133-24335EDD-A514-4011-A57A-40AD679E4A85Q37541469-CF6ACD07-D841-4D09-AD32-46FBF9E9C788Q37683553-E9AC648B-83F2-407C-921A-24FF819FF70AQ37699812-E6C09F74-9CAD-444D-91A8-B72DE5D4EC04Q38335622-E5ACE9C4-E2D4-4EBE-9DF8-D3848F9D52CAQ38554636-829048AC-F3B4-4C62-B44F-F96D18532EA2Q38781550-1F6D739A-450A-4F58-8E33-435E7FB592C4Q38845590-04783E00-AA84-4B2A-A7AF-25A48DB6AC3AQ39586997-1042DDA8-DCD8-4714-87B4-982540BB1DE5Q41641093-53CC6F9E-9510-44B7-BD6B-FC8EECE54B7D
P2860
The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@ast
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@en
type
label
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@ast
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@en
prefLabel
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@ast
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@en
P2093
P2860
P356
P1476
The detrimental effects of IFN ...... nd renal vascular rarefaction.
@en
P2093
Celine C Berthier
Deborah Mattinzoli
Maria Pia Rastaldi
Mariana J Kaplan
Seth G Thacker
P2860
P304
P356
10.4049/JIMMUNOL.1001782
P407
P577
2010-08-30T00:00:00Z